Matinas BioPharma receives NYSE noncompliance notice
Source: SeekingAlpha
2025-01-10 17:23:23 ET
More on Matinas Biopharma
- Matinas BioPharma plunges as deal for lead asset falls apart
- Seeking Alpha’s Quant Rating on Matinas Biopharma
- Historical earnings data for Matinas Biopharma
- Financial information for Matinas Biopharma
Read the full article on Seeking Alpha
For further details see:
Matinas BioPharma receives NYSE noncompliance notice
Matinas Biopharma Holdings Inc.
NASDAQ: MTNB
MTNB Trading
-1.76% G/L:
$0.6029 Last:
11,685 Volume:
$0.62 Open:
MTNB Latest News
March 11, 2025 07:00:00 am
Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors
February 13, 2025 05:00:00 pm
Matinas BioPharma Announces Agreement for the Acquisition of Preferred Stock and Appointment of Dr. Robin L. Smith to the Board of Directors
February 07, 2025 07:30:00 am
Matinas BioPharma Appoints Evelyn D'An to Board of Directors as Audit Committee Chair
MTNB Stock Data
$4,074,337
6,111,506
2.36%
12
N/A
Biotechnology & Life Sciences
Healthcare
US
Bedminster
